Clinical Trial Update: Effect of Low Sodium Oxybate (LXB) on Autonomic Symptom Burden in Idiopathic Hypersomnia Patients With Postural Tachycardia Syndrome [Phase 4]

View source ↗

Summary

This Phase 4 trial from Stanford investigates whether Low Sodium Oxybate (LXB) reduces autonomic symptoms in patients with idiopathic hypersomnia and postural o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia
• Postural Orthostatic Tachycardia Syndrome

Drugs mentioned

• Low Sodium Oxybate (LXB) (sodium oxybate (low-sodium formulation))

Snippet

Sponsor: Stanford University | Conditions: Idiopathic Hypersomnia, POTS - Postural Orthostatic Tachycardia Syndrome | Phase 4 | Status: NOT_YET_RECRUITING